VanEck Associates’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-49,698
Closed -$6.63M 1427
2026
Q1
$6.63M Buy
49,698
+1,746
+4% +$278K 0.01% 720
2025
Q4
$8.32M Buy
47,952
+38,012
+382% +$6.25M 0.01% 623
2025
Q3
$1.9M Sell
9,940
-1,626
-14% -$299K ﹤0.01% 992
2025
Q2
$3.45M Sell
11,566
-741
-6% -$233K ﹤0.01% 855
2025
Q1
$4.05M Buy
12,307
+304
+3% +$91.8K 0.01% 791
2024
Q4
$3.49M Sell
12,003
-1,071
-8% -$331K ﹤0.01% 820
2024
Q3
$3.6M Buy
13,074
+1,201
+10% +$396K ﹤0.01% 761
2024
Q2
$3.53M Buy
11,873
+259
+2% +$87.9K 0.01% 702
2024
Q1
$4.77M Buy
11,614
+365
+3% +$141K 0.01% 603
2023
Q4
$4.06M Sell
11,249
-2
-0% -$705 0.01% 601
2023
Q3
$3.69M Buy
11,251
+2,871
+34% +$904K 0.01% 584
2023
Q2
$2.52M Buy
+8,380
New +$2.41M 0.01% 668
2021
Q1
Sell
-2,936
Closed -$624K 1231
2020
Q4
$624K Buy
2,936
+1,958
+200% +$404K ﹤0.01% 751
2020
Q3
$179K Buy
+978
New +$178K ﹤0.01% 832

Other funds holding MOH

VanEck Associates's MOH Position: Q2 2026 in Review

VanEck Associates sold out of Molina Healthcare (MOH) in Q2 2026, closing a stake of 49,698 shares — an estimated $6.63M sold.

VanEck Associates first reported a position in MOH in Q3 2020 and held it in 14 quarters. The position peaked at $8.32M in Q4 2025. 599 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • VanEck Associates reported no remaining Molina Healthcare position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 49,698 Molina Healthcare shares in Q2 2026, an estimated $6.63M.
  • VanEck Associates first reported a position in Molina Healthcare in Q3 2020 and held it in 14 quarters.
  • VanEck Associates's Molina Healthcare position peaked at $8.32M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.